Literature DB >> 11789510

Legal prerequisites for clinical trials under the revised Declaration of Helsinki and the European Convention on Human Rights and Biomedicine.

H Rosenau1.   

Abstract

Biomedical research is a perennially controversial subject. While the provisions of the Revised Declaration of Helsinki enjoy world-wide acceptance, they are increasingly placed in question--not least by the Council of Europe's Bioethics Convention, which allows non-therapeutic research in restricted cases on those incapable of giving informed consent. Taking as its starting-point the fundamental conflict between the general interest in research and the individual interests of the patients concerned, this article analyses the conditions under which medical experimentation on human beings is permissible. The article recognises the model of risk/benefit analysis and the doctrine of informed consent as equally valid core principles which do not conflict with restricted, non-therapeutic research, whether on patients who lack the capacity to consent or in placebo-controlled trials.

Entities:  

Keywords:  Biomedical and Behavioral Research; Legal Approach; Nuremberg Code

Mesh:

Substances:

Year:  2000        PMID: 11789510     DOI: 10.1163/15718090020523106

Source DB:  PubMed          Journal:  Eur J Health Law        ISSN: 0929-0273


  3 in total

1.  The convention on human rights and biomedicine and the use of coercion in psychiatry.

Authors:  T Tannsjo
Journal:  J Med Ethics       Date:  2004-10       Impact factor: 2.903

2.  Efficacy and safety of subcutaneous immunotherapy with a mixture of glutaraldehyde-modified extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae , and Blomia tropicalis.

Authors:  Ricardo Cardona-Villa; Susana Uribe-Garcia; Víctor Daniel Calvo-Betancur; Jose Fernando Cantillo; Enrique Fernández-Caldas
Journal:  World Allergy Organ J       Date:  2022-09-08       Impact factor: 5.516

3.  Health, human rights, and the conduct of clinical research within oppressed populations.

Authors:  Edward J Mills; Sonal Singh
Journal:  Global Health       Date:  2007-11-08       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.